Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
Holding CRSP?
Track your performance easily
See the Price Targets and Ratings of:
CRSP Analyst Ratings
Moderate Buy
10 Buy
6 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CRSP Stock 12 Month Forecast
Average Price Target
$74.00
▲(49.53% Upside)
| Highest Price Target$105.00 | Average Price Target$74.00 | Lowest Price Target$30.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Reiterated
08/12/24
Morgan Stanley
Reiterated
08/08/24
JMP Securities
Reiterated
08/08/24
Oppenheimer
Assigned
08/06/24
Evercore ISI
Assigned
08/06/24
Barclays
Reiterated
08/06/24
William Blair
Reiterated
08/06/24
TD Cowen
Assigned
08/06/24
Needham
Reiterated
08/06/24
BMO Capital
Reiterated
08/06/24
Robert W. Baird
$52
Hold
5.07%
Upside
Reiterated
08/06/24
Crispr Therapeutics AG: A Cautious Hold Amidst Revenue Recognition Delays and Evolving CAR-T Pipeline
Stifel Nicolaus
$60→$59
Hold
19.22%
Upside
Reiterated
08/06/24
Crispr Therapeutics price target lowered to $59 from $60 at StifelCrispr Therapeutics price target lowered to $59 from $60 at Stifel
Piper Sandler
$105
Buy
112.16%
Upside
Reiterated
08/06/24
Crispr Therapeutics AG (CRSP) Receives a Buy from Piper Sandler
Chardan Capital
$112→$94
Buy
89.94%
Upside
Reiterated
08/05/24
Crispr Therapeutics price target lowered to $94 from $112 at ChardanCrispr Therapeutics price target lowered to $94 from $112 at Chardan
Leerink Partners
$80→$68
Buy
37.40%
Upside
Reiterated
08/05/24
Crispr Therapeutics AG Poised for Growth: Foroohar Maintains Buy Rating Amid Pipeline Progress and Strong Financials
Best Analysts Covering Crispr Therapeutics AG
Which Analyst Should I Follow If I Want to Buy CRSP and Sell After:
1 Month
xxx
Success Rate
13/20 ratings generated profit
Average Return
+11.07%
assigned a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.00% of your transactions generating a profit, with an average return of +11.07% per trade.
3 Months
xxx
Success Rate
9/15 ratings generated profit
Average Return
+18.88%
initiated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +18.88% per trade.
1 Year
Success Rate
9/15 ratings generated profit
Average Return
+21.49%
initiated a buy rating 2 months ago
Copying Anthony Butler's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +21.49% per trade.
2 Years
xxx
Success Rate
7/15 ratings generated profit
Average Return
+16.05%
initiated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 46.67% of your transactions generating a profit, with an average return of +16.05% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CRSP Analyst Recommendation Trends
Rating
Apr 24
May 24
Jun 24
Jul 24
Aug 24
Strong Buy
4
12
14
11
10
Buy
16
7
7
4
4
Hold
4
5
6
6
6
Sell
1
1
1
2
3
Strong Sell
1
0
0
0
0
total
26
25
28
23
23
Each month's total comprises the sum of three months' worth of ratings.
CRSP Financial Forecast
CRSP Stock Forecast FAQ
What is CRSP’s average 12-month price target, according to analysts?
Based on analyst ratings, Crispr Therapeutics AG’s 12-month average price target is $74.00.
What is CRSP’s upside potential, based on the analysts’ average price target?
Crispr Therapeutics AG has 49.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CRSP a Buy, Sell or Hold?
Crispr Therapeutics AG has a consensus rating of Moderate Buy which is based on 10 buy ratings, 6 hold ratings and 2 sell ratings.
What is Crispr Therapeutics AG’s price target?
The average price target for Crispr Therapeutics AG is $74.00. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $105.00 ,the lowest forecast is $30.00. The average price target represents 49.53% Increase from the current price of $49.49.
The highest analyst price target is $105.00 ,the lowest forecast is $30.00. The average price target represents 49.53% Increase from the current price of $49.49.
What do analysts say about Crispr Therapeutics AG?
Crispr Therapeutics AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of CRSP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.